
Series E+ · New York
Caretech · B2B
$65MDebt FinancingMar 2026
Led by Goldcrest Capital, Goldman Sachs Alternatives +3 more
Recent raisesNo open roles right now
Sage has nothing open on the board today. We've tracked 6 roles here so far, and new ones show up here on their own.
Explore all roles